seronegative spondyloarthropathy Flashcards

1
Q

features of spondyloarthropathy

A

Involvement of spine and Sacro-Iliac Joint (SIJ)
Peripheral arthritis – asymmetrical and large lower limb joints
Negative Rheumatoid factor
Genetic factor HLA-B27
Extra-articular features: skin, iritis of eye
Enthesitis - inflammation at ligament and tendon insertion
Familial incidence
More common in males
Overlapping of clinical features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ankylosing spondylitis

A

Chronic progressive inflammatory disease

Spine and SIJ predominantly affected

Peripheral joint involvement in 60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

epidemiology

A
Prevalence of 0.1-0.2%
Typical presentation in ‘young males’
Male: Female = 3:1 or 5:1
Age of onset 15 - 30 
Less disabling in women: older age >40
95% have HLA-B27 factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathology

A

Affects synovial and cartilaginous joints

Involvement of synovium, articular capsule and ligaments where attached to bone

Enthesitis - inflammation site of attachment ligament or tendon to bone*
Adjacent bony erosions

Reactive bone formation ‘bridging’ between vertebral body margins – syndesmophytes

Inflammation followed by fusion partial / complete of joints

Calcification of ALL and PLL - spinal fusion - ‘Bamboo spine’

Inflammation SIJ (Sacroilitis)

Erosion symphysis pubis

Ankylosis costovertebral joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enthesitis

A
Common sites 
TA insertion 
Iliac crest
PSIS/ASIS 
Costochondral junction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

radiological changes

A
Sclerosis / erosion SIJ
Fusion of SIJ
Syndesmophytes
‘Squaring’ of vertebrae
Calcification Anterior Longitudinal Ligament (ALL) + Posterior Longitudinal Ligament (PLL)
Tufting iliac crest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

lab investigations

A

Raised Erythrocyte Sedimentation Rate (ESR)
Marker of inflammation
Positive HLA-B27 Factor
Negative Rh Factor (seronegative)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

articular features

A
Low back pain +/- buttock pain- Insidious onset
Peripheral Joints- hips and shoulders most common
Spinal stiffness
Deep / dull aching
Early morning stiffness 
Difficulty getting out of bed 
‘log roll’ manoeuvre
Duration: 1 - 2 hours
Worse after period of immobility
Better with exercise 

Pain
Worse at rest & eased by mild exercise
Night pain especially in second half of night
Postural changes
Loss of normal lumbar lordosis and increased thoracic kyphosis
Increasingly flexed posture
Pain at tendon insertion sites
TA & plantar fascia
Bony tenderness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

clinical features - systemic involvement

A
Fatigue 
Weight loss
Malaise
Low grade pyrexia
Anaemia
Iritis (20%)
Lung disease (<1%)
Cardiac disease (<1%)
Crohn’s disease + Ulcerative colitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

clinical features other

A

Neurological
Atlantoaxial involvement +/- subluxation
Risk of spinal cord compression

Costovertebral joints
Ankylosis joints - Restricted chest expansion
c/o Shortness of breath (SOB), chest pain/discomfort

Cardiovascular
Aortic valve incompetence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

progression of AS

A

Initial changes in SIJs and lumbosacral region

Progresses through the spine

Inflammatory changes initially

Progressive stiffness

Ossification costovertebral joints

X-Ray ankylosis SIJ & formation of syndesmophytes‘
Bamboo’ spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

medical mgmt of AS

A

Patient education*

Pharmacological Rx (Medications)

Surgery
Correction of spinal deformity
THR, TKR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacological treatment

A

NSAIDs are recommended as first-line Rx for pain and stiffness.
Cardiovascular, GI and renal risks

Analgesics, such as paracetamol and opioid (like) drugs, might be considered for residual pain after previously recommended treatments have failed, are contraindicated, and/or poorly tolerated

Corticosteroid injections for local musculoskeletal inflammation may be considered.

The use of systemic glucocorticoids for axial disease is not supported by evidence.

There is no evidence for the efficacy of Disease Modifying Anti-Rheumatic Drugs (DMARDs) (e.g MTX) for axial (spinal) disease.

DMARDS may be considered in peripheral arthritis.

Anti-TNF therapy should be given to patients with persistently high disease activity despite conventional treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

physio assessment subjective AS

A

Subjective Assessment
Problems arising …multiple symptoms?
Symptoms body chart
One joint or multiple joints ?
Pain behaviour (24 hour, aggs/eases, quality of pain)
Stiffness, Swelling? Crepitus, weakness etc
Functional difficulty
History of onset ?insiduous
General health –extra-articular symptoms
Investigations
Management to date
Drug history
Outcome measures: AS therapy screening tools; Stoke AS Spinal Score (SASSS), Bath indices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PA - AS

A
Postural changes
‘Stooped posture’
Poking chin
 thoracic kyphosis
Loss of lumbar lordosis
Flexion hips + knees
Shortened pectorals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

assessment for AS

A

cervical spine - flexion/extension
rotation
side flexion
tragus to wall test

Lumbar spine

  • forward flexion
  • modified schober’s test
  • lateral flexion
  • trunk rotation
  • height

ROM peripheral joints
E.g. Goniometry

Chest expansion
Difference between Inspiration / expiration
4th ICS and at Xiphoid process (Normal 5cm)

Pulmonary Function tests (PFT’s) – test lung volumes

Compression SIJ’s: assessing for pain 
Presence of tenderness
Ischial tuberosities, greater trochanters
Costochondral junctions
ASIS
Iliac crest
Calcaneii
Pubic symphysis
17
Q

BASMI AS

A
Cervical rotation
Tragus to wall distance
Lateral flexion spine
Modified Schober’s test
Intermalleolar distance
18
Q

assessment of function AS

A

Self-reported
E.g Bath Ankylosing Spondylitis Functional Index
http://www.basdai.com/BASFI.php

Functional tests
Mobility tests.. Timed walks
Timed functional tasks
Battery of tests of function/mobility

19
Q

non-pharmacological treatment AS

A

The cornerstone of non-pharmacological treatment of patients with AS is patient education and regular exercise.

Home exercises are effective.

Physical therapy with supervised exercises, land or water based, individually or in a group, should be preferred as these are more effective than home exercises.

Patient associations and self-help groups may be useful (e.g ASAI, AI)

20
Q

physiotherapy for AS

A

Education
Self-Management
Exercise should be individually tailored
Exercise
Land based or Hydrotherapy (van Tubergen and Hidding, 2002)
Supervised exercise more beneficial than home exercise (Dagfinrud et al, 2008
Postural alignment
General Cardiovascular exercise.. How?
Maintain/improve joint range and flexibility incl Cervical /Thoracic spine and rib mobility
Strengthening
Which muscle groups most likely to be weaker? (think of posture)
Pain modalities … Examples?
What Exercise precautions should be considered?

21
Q

exercise precautions AS

A

Heart Abnormalities
Severely restricted breathing
Atlanto-occipital/Atlanto-axial subluxation
Osteoporosis +/- vertebral crush fractures

22
Q

psoriatic arthritis

pathology

A
An inflammatory arthritis (spondyloarthropathy) associated with psoriasis
Seronegative –ve Rh factor
2% population have Psoriasis 
PsA: 1% of population 
Age of onset 20- 40 
Males = Females
HLA B27 +/- spinal involvement
HLA DR4 +/- polyarthritis
75% psoriasis precedes arthritis
10% arthritis precedes psoriasis
15% synonymous

unknown
abnormal responses to bacterial antigens
associated genes HLA-C

23
Q

Psoriatic arthritis clinical features (PsA)

A

Any form of psoriasis
Peripheral symmetrical polyarthritis +/- axial involvement
Asymmetrical spondylitis and sacroiliitis
Typical inflammatory involvement DIPJ’s
Dactylitis (‘sausage digits’)
Telescoping of fingers (‘opera glass hands’)
Nail lesions (pitting)
Enthesitis

24
Q

patterns of PsA

A

30%-50% oligoarticular (asymmetrical) or monoarthritis
5%-24% spondyloarthropathy +/- hip, and shoulder
18%-50% polyarticular (symmetrical, polyarthropathy)
Indistinguishable from RA
8% DIP arthritis - classic presentation
Frequently accompanied by nail dystrophy
2% arthritis mutilans - rare destructive progressive form
“telescoping digits” ( hands and feet)
widespread ankylosis

25
Q

PsA joint changes

A

normal joint
marginal erosions
erosions progessing centrally, new bone formation whiskering
apparent joint widening
pencil in cup central erosion of the distal phalanx and further marginal bony proliferation whittling of proximal phalanx

26
Q

clinical features of PsA

A

DIPJ involvement
Inflammatory changes & psoriatic changes
(onycholysis - pitting - ridging - erosion of nail)

Spinal involvement
Sacroiliitis
Spondylitis
Cervical spine - subluxation

Systemic
Early morning stiffness
Fatigue
Malaise /Low grade fever

Enthesitis
Achilles tendon/ plantar fascia /pelvis /spine

Ocular
Conjunctivitis 20%

27
Q

investigations

PsA

A

Blood Tests
Increased ESR
50% have HLA-B27
-ve Rh F

X-Ray
Spinal changes similar to AS
Syndesmophytes/ enthesitis 
Peripheral changes: 
‘whiskering’
Ankylosis
Osteolysis
Cup-and-pencil deformity 
Erosion of one end of bone with expansion of the base of the metacarpal
28
Q

Diagnosis: CASPAR criteria

PsA

A

Current psoriasis, hx or family hx of psoriasis (2 points)
Psoriatic nail dystrophy e.g. onycholysis, pitting, and hyperkeratosis observed on P/E (1 point)
A negative test result for the presence of RhF rheumatoid factor (1 point)
Either current or hx of dactylitis (swelling of an entire digit) (1 point)
Radiographic evidence of juxta-articular new bone formation appearing as ill-defined ossification near joint margins (excluding osteophyte formation) on plain radiographs of the hand or foot (1 point)

29
Q

PsA treatment

A

Similar guidelines to RA or AS ( if spinal involvement).
Pharmacological
NSAID’s
DMARDS: Methotrexate/ Sulfazalazine/Leflunomide
Anti –TNFs

Treatment for Psoriasis e.g. Meds/UV therapy

30
Q

non-pharmacological treatment RsA

A
Education 
Exercise 
Hydrotherapy 
Aerobic etc...
Modalities (Caution with skin lesions) 
Heat/Cold
TENS 
Posture correction 
Orthoses/ Footwear 
Ergonomics 
Hand Therapy + OT